Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1998
12/01/1998US5843733 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
12/01/1998US5843722 Coccidiosis poultry vaccine
12/01/1998US5843711 Diphtheria toxin receptor-binding region
12/01/1998US5843710 Vaccines against animal parasitic nematodes
12/01/1998US5843707 Nucleic acid encoding a novel P-selectin ligand protein
12/01/1998US5843706 Vaccines against animal parasitic nematodes
12/01/1998US5843690 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
12/01/1998US5843688 Isolated tyrosinase derived peptides and uses thereof
12/01/1998US5843687 Isolated, tyrosinase derived peptides and uses thereof
12/01/1998US5843686 Methods of diagnosing metastatic cancer with MTS-1 protein
12/01/1998US5843678 Osteoprotegerin binding proteins
12/01/1998US5843676 Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
12/01/1998US5843672 Allergenic proteins and peptides from dog dander and uses therefor
12/01/1998US5843668 Human SQM1 protein homolog
12/01/1998US5843648 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
12/01/1998US5843641 Methods for the daignosis, of familial amyotrophic lateral sclerosis
12/01/1998US5843639 Hepatitis C virus epitopes
12/01/1998US5843636 Hepatitis C virus epitopes
12/01/1998US5843464 Synthetic chimeric fimbrin peptides
12/01/1998US5843463 Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
12/01/1998US5843462 Diphtheria toxin epitopes
12/01/1998US5843461 Group B streptococcus type II polysaccharide-tetanus toxoid conjugate vaccines
12/01/1998US5843460 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
12/01/1998US5843458 Recombinant human cytomegalovirus having a US2 deletion
12/01/1998US5843456 Alvac poxvirus-rabies compositions and combination compositions and uses
12/01/1998US5843454 HIV immunogenic complexes
12/01/1998US5843451 Intranasal immunization against viral infection using viral glycoprotein subunit vaccine
12/01/1998US5843450 Hepatitis GB Virus synthetic peptides and uses thereof
12/01/1998US5843448 Tumor rejection antigen precursor
12/01/1998US5843446 Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
12/01/1998US5843445 Method of treating rheumatoid arthritis with type II collagen
12/01/1998US5843441 Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma
12/01/1998US5843440 Cellular and serum protein anchors for modulating pharmacokinetics
12/01/1998US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843435 Immunotherapy of cancer with allogeneic lymphocytes
12/01/1998US5843426 Salmonella vaccines
12/01/1998US5843425 Transplantation and graft-versus-host-disease
12/01/1998US5843397 Cytotoxic therapy for graft rejection
12/01/1998CA2053346C Microcapsule compositions for torical treatment
12/01/1998CA2022429C Methods and compositions for ameliorating the symptoms of sepsis
11/1998
11/30/1998CA2233577A1 Histidine kinase
11/30/1998CA2233572A1 Histidine kinase
11/30/1998CA2233554A1 Novel compounds
11/30/1998CA2233547A1 Histidine kinase
11/30/1998CA2233539A1 Histidine kinase
11/29/1998CA2233565A1 Novel compounds
11/29/1998CA2233561A1 Novel compounds
11/27/1998CA2232817A1 Novel compounds
11/26/1998WO1998053078A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
11/26/1998WO1998053077A1 Live attenuated virus vaccines for equine encephalitis viruses
11/26/1998WO1998053075A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
11/26/1998WO1998053071A1 Modulators of tissue regeneration
11/26/1998WO1998053066A1 Smad2 phosphorylation and interaction with smad4
11/26/1998WO1998053048A1 Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
11/26/1998WO1998052976A1 Method for the production of non-immunogenic proteins
11/26/1998WO1998052963A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998WO1998052962A1 Oligonucleotide adjuvant
11/26/1998WO1998052607A1 88kda tumorigenic growth factor and antagonists
11/26/1998WO1998052606A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998WO1998052605A1 Immunopotentiating composition
11/26/1998WO1998052604A1 Therapeutic or prophylactic use of fibronectin-binding protein i (sfbi) as adjuvant
11/26/1998WO1998052603A2 An influenza enveloped dna vaccine
11/26/1998WO1998052588A1 Therapeutic agents for respiratory diseases
11/26/1998WO1998052582A2 Non-myeloablative tolerogenic treatment
11/26/1998WO1998052581A1 Vectors and methods for immunization or therapeutic protocols
11/26/1998WO1998052573A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/26/1998CA2783134A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis
11/26/1998CA2291216A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
11/26/1998CA2291156A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998CA2290783A1 Modulators of tissue regeneration
11/26/1998CA2290778A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998CA2290774A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis
11/26/1998CA2290602A1 88kda tumorigenic growth factor and antagonists
11/26/1998CA2290367A1 Non-myeloablative tolerogenic treatment
11/26/1998CA2289906A1 Smad2 phosphorylation and interaction with smad4
11/26/1998CA2289741A1 Oligonucleotide adjuvant
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879884A2 Novel CD4 derivatives
11/25/1998EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998EP0879881A1 A human gene similar to a secreted protein frizb (ATG-1639)
11/25/1998EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998EP0879879A2 Polypeptide deformylase 1 (Def1)
11/25/1998EP0879284A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same
11/25/1998EP0879244A1 Mycoplasma recombinant polypeptide vaccines
11/25/1998EP0879240A1 Human criptin growth factor
11/25/1998EP0879060A1 Vaccines against varicella zoster virus gene 63 product
11/25/1998EP0879056A1 MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN$m(3) AND RIBAVIRIN$m(3) ANALOGS IN ACTIVATED T-LYMPHOCYTES
11/25/1998EP0720624B1 Retargeting antibodies
11/25/1998EP0710118B1 Vaccine against gram-negative bacterial infections
11/25/1998EP0697023B1 3-(aminoacyl-amino)-saccharides and method for preparing them
11/25/1998EP0695189B1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors
11/25/1998EP0663916B1 O-alkylated rapamycin derivative and its use, particularly as immunosuppressant
11/25/1998EP0661998B1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection with aids
11/25/1998EP0602237B1 N-acetylglucosaminyltransferase v coding sequences
11/25/1998EP0592636B1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
11/25/1998EP0553113B1 Adhesion receptors for pathogenic or opportunistic microorganisms
1 ... 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 ... 1823